Taliaz is the developer of Predictix, an AI-based branded platform designed to help doctors deliver personalized medicine. Based on proprietary IP, Predictix generates doctor-centric therapy prediction reports for individual patients. The Predictix reports are managed as a decision-support tool, enabling general practitioners and specialists to make informed treatment choices for improved patient outcomes.
The companys flagship application addresses depression. The Predictix Anti-Depressant AI system is a noninvasive, user-friendly application that analyzes genomic, clinical, and demographic data to generate a personalized report that includes statistical analysis on the efficacy of antidepressants and their side effects, allowing doctors to optimize antidepressant treatment strategies for enhanced patient outcomes. The application is currently available for commercial use in the EU and Israel.
Taliaz mission is to empower doctors and patients with artificial intelligence technology to improve the assessment, treatment, and management of mental health disorders.